These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 10561371)

  • 1. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
    Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A
    J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concurrent chemoradiotherapy for T4 and/or M1 LYM squamous cell carcinoma of the esophagus].
    Miyata Y; Seki S; Ohtsu A; Kaneko K; Nakamura A
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1174-9. PubMed ID: 10945013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
    Higuchi K; Komori S; Tanabe S; Katada C; Azuma M; Ishiyama H; Sasaki T; Ishido K; Katada N; Hayakawa K; Koizumi W;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):872-9. PubMed ID: 24867539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma: Kitasato digestive disease & oncology group trial (KDOG 0501).
    Higuchi K; Koizumi W; Tanabe S; Sasaki T; Katada C; Ishiyama H; Hayakawa K
    Radiother Oncol; 2008 Jun; 87(3):398-404. PubMed ID: 18405987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
    Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
    Zenda S; Hironaka S; Boku N; Yamazaki K; Yasui H; Fukutomi A; Yoshino T; Onozawa Y; Nishimura T
    Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Kumekawa Y; Kaneko K; Ito H; Kurahashi T; Konishi K; Katagiri A; Yamamoto T; Kuwahara M; Kubota Y; Muramoto T; Mizutani Y; Imawari M
    J Gastroenterol; 2006 May; 41(5):425-32. PubMed ID: 16799883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
    Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus.
    Ohtsu A; Yoshida S; Boku N; Fujii T; Miyata Y; Hosokawa K; Koba I; Shimizu W; Ogino T
    Jpn J Clin Oncol; 1995 Dec; 25(6):261-6. PubMed ID: 8523823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
    Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR
    J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial.
    Ishida K; Iizuka T; Ando N; Ide H
    Jpn J Clin Oncol; 1996 Oct; 26(5):310-5. PubMed ID: 8895670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
    Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II clinical trial of concurrent chemoradiotherapy (cisplatin plus 5-fluorouracil) for esophageal cancer].
    Lin Q; Gao XS; Qiao XY; Chen K; Wang YD; Zhou ZG
    Ai Zheng; 2008 Oct; 27(10):1077-81. PubMed ID: 18851788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.